Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now owns 2,245 shares in the company, valued at approximately $1,152,089.10. This trade represents a 43.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Intuitive Surgical Price Performance
Shares of NASDAQ ISRG opened at $514.59 on Friday. The firm's 50-day moving average is $511.92 and its two-hundred day moving average is $532.42. Intuitive Surgical, Inc. has a 12-month low of $367.39 and a 12-month high of $616.00. The company has a market capitalization of $183.29 billion, a PE ratio of 80.28, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Institutional Trading of Intuitive Surgical
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Atala Financial Inc purchased a new position in Intuitive Surgical in the 4th quarter valued at about $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. Global Financial Private Client LLC grew its stake in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the period. Finally, BankPlus Trust Department acquired a new position in Intuitive Surgical in the 4th quarter valued at $28,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
Analyst Upgrades and Downgrades
ISRG has been the topic of several analyst reports. Royal Bank of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Piper Sandler cut their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $598.95.
Read Our Latest Report on ISRG
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
